LeadStory

Euronews

EU-U.S. trade deal leaves future of pharma tariffs uncertain

Euronews · New
Euronews
Euronews
New

Despite a new EU-U.S. trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a U.S. national security investigation that could later impose duties of up to 15%.

Breakdown
  • Pharmaceutical tariffs remain at 0% despite the new EU-US trade deal.
  • Most EU goods imported to the US will now face a 15% tariff. 44s
  • The US is reviewing pharmaceutical imports for national security concerns. 52s
  • Any changes to pharma tariffs will be announced after the US review is complete. 1m 0s
  • The European Commission expects a 15% cap on pharma tariffs, but the future remains undecided. 1m 4s
BusinessInternational PoliticsEconomy